ANIP
Price
$93.05
Change
-$0.32 (-0.34%)
Updated
Sep 26 closing price
Capitalization
2.02B
39 days until earnings call
COLL
Price
$34.41
Change
-$0.24 (-0.69%)
Updated
Sep 26 closing price
Capitalization
1.08B
40 days until earnings call
Interact to see
Advertisement

ANIP vs COLL

Header iconANIP vs COLL Comparison
Open Charts ANIP vs COLLBanner chart's image
ANI Pharmaceuticals
Price$93.05
Change-$0.32 (-0.34%)
Volume$230.77K
Capitalization2.02B
Collegium Pharmaceutical
Price$34.41
Change-$0.24 (-0.69%)
Volume$291.11K
Capitalization1.08B
ANIP vs COLL Comparison Chart in %
Loading...
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COLL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIP vs. COLL commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIP is a StrongBuy and COLL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (ANIP: $93.05 vs. COLL: $34.41)
Brand notoriety: ANIP and COLL are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ANIP: 44% vs. COLL: 69%
Market capitalization -- ANIP: $2.02B vs. COLL: $1.08B
ANIP [@Pharmaceuticals: Generic] is valued at $2.02B. COLL’s [@Pharmaceuticals: Generic] market capitalization is $1.08B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIP’s FA Score shows that 1 FA rating(s) are green whileCOLL’s FA Score has 1 green FA rating(s).

  • ANIP’s FA Score: 1 green, 4 red.
  • COLL’s FA Score: 1 green, 4 red.
According to our system of comparison, COLL is a better buy in the long-term than ANIP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIP’s TA Score shows that 4 TA indicator(s) are bullish while COLL’s TA Score has 3 bullish TA indicator(s).

  • ANIP’s TA Score: 4 bullish, 4 bearish.
  • COLL’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ANIP is a better buy in the short-term than COLL.

Price Growth

ANIP (@Pharmaceuticals: Generic) experienced а -3.86% price change this week, while COLL (@Pharmaceuticals: Generic) price change was -3.75% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

ANIP is expected to report earnings on Nov 05, 2025.

COLL is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANIP($2.02B) has a higher market cap than COLL($1.08B). ANIP has higher P/E ratio than COLL: ANIP (49.06) vs COLL (32.46). ANIP YTD gains are higher at: 68.325 vs. COLL (20.105). COLL has higher annual earnings (EBITDA): 347M vs. ANIP (89M). ANIP (224M) and COLL (222M) have equal amount of cash in the bank . ANIP has less debt than COLL: ANIP (622M) vs COLL (829M). ANIP has higher revenues than COLL: ANIP (747M) vs COLL (707M).
ANIPCOLLANIP / COLL
Capitalization2.02B1.08B186%
EBITDA89M347M26%
Gain YTD68.32520.105340%
P/E Ratio49.0632.46151%
Revenue747M707M106%
Total Cash224M222M101%
Total Debt622M829M75%
FUNDAMENTALS RATINGS
ANIP vs COLL: Fundamental Ratings
ANIP
COLL
OUTLOOK RATING
1..100
6968
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
66
Overvalued
PROFIT vs RISK RATING
1..100
2547
SMR RATING
1..100
9352
PRICE GROWTH RATING
1..100
4056
P/E GROWTH RATING
1..100
948
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COLL's Valuation (66) in the Pharmaceuticals Other industry is in the same range as ANIP (94). This means that COLL’s stock grew similarly to ANIP’s over the last 12 months.

ANIP's Profit vs Risk Rating (25) in the Pharmaceuticals Other industry is in the same range as COLL (47). This means that ANIP’s stock grew similarly to COLL’s over the last 12 months.

COLL's SMR Rating (52) in the Pharmaceuticals Other industry is somewhat better than the same rating for ANIP (93). This means that COLL’s stock grew somewhat faster than ANIP’s over the last 12 months.

ANIP's Price Growth Rating (40) in the Pharmaceuticals Other industry is in the same range as COLL (56). This means that ANIP’s stock grew similarly to COLL’s over the last 12 months.

COLL's P/E Growth Rating (8) in the Pharmaceuticals Other industry is significantly better than the same rating for ANIP (94). This means that COLL’s stock grew significantly faster than ANIP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIPCOLL
RSI
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
60%
MACD
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 24 days ago
74%
Bullish Trend 25 days ago
71%
Declines
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
65%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COLL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSCFX31.070.44
+1.44%
Mairs & Power Small Cap
NRFAX12.920.13
+0.99%
Natixis AEW Global Focused Real Estate A
JVAIX40.100.37
+0.93%
JPMorgan Value Advantage L
JGEMX13.260.11
+0.84%
JHancock Global Equity R6
NDXKX43.390.18
+0.42%
Shelton Nasdaq-100 Index K

ANIP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIP has been loosely correlated with ORGO. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIP jumps, then ORGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIP
1D Price
Change %
ANIP100%
-0.34%
ORGO - ANIP
49%
Loosely correlated
-12.39%
AMRX - ANIP
37%
Loosely correlated
+1.56%
DRRX - ANIP
34%
Loosely correlated
N/A
PRGO - ANIP
33%
Loosely correlated
+3.32%
COLL - ANIP
32%
Poorly correlated
-0.69%
More

COLL and

Correlation & Price change

A.I.dvisor indicates that over the last year, COLL has been loosely correlated with AMPH. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if COLL jumps, then AMPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COLL
1D Price
Change %
COLL100%
-0.69%
AMPH - COLL
40%
Loosely correlated
+1.86%
AMRX - COLL
40%
Loosely correlated
+1.56%
VTRS - COLL
38%
Loosely correlated
+0.32%
ALKS - COLL
36%
Loosely correlated
+2.80%
ZTS - COLL
33%
Poorly correlated
+1.68%
More